For: | Rajendraprasad S, Wheeler M, Wieruszewski E, Gottwald J, Wallace LA, Gerberi D, Wieruszewski PM, Smischney NJ. Clonidine use during dexmedetomidine weaning: A systematic review. World J Crit Care Med 2023; 12(1): 18-28 [PMID: 36683967 DOI: 10.5492/wjccm.v12.i1.18] |
---|---|
URL: | https://www.wjgnet.com/2220-3141/full/v12/i1/18.htm |
Number | Citing Articles |
1 |
Young R. Lee, Alayna Garza, Laureen Kiama. Guanfacine Use in the ICU for Management of Sedation Weaning. Clinical Drug Investigation 2025; 45(4): 169 doi: 10.1007/s40261-025-01434-x
|
2 |
Hsien Yi Yang, Cyrus Nensey. Xylazine Withdrawal: A Case Report From the Intensive Care Unit to the Medical Ward. Cureus 2025; doi: 10.7759/cureus.87545
|
3 |
Kory S. London, Samantha Huo, Lauren Murphy, TaReva Warrick-Stone, Dennis Goodstein, Maeve Montesi, Meg Carter, Sabrina Butt, Karen Alexander, Wayne Satz, Abriana Tasillo, Lin Xu, Maya Arora, Emily Casey, Rita McKeever, Margaret Lowenstein, Philip Durney, Brendan Hart, Jeanmarie Perrone. Severe Fentanyl Withdrawal Associated With Medetomidine Adulteration: A Multicenter Study From Philadelphia, PA. Journal of Addiction Medicine 2025; doi: 10.1097/ADM.0000000000001560
|
4 |
Cathrine Anne McKenzie, Timothy Simon Walsh. Pharmacology of Alpha-2 Agonists Applied to Sedation, Sleep, and Analgesia. Critical Care Clinics 2025; doi: 10.1016/j.ccc.2025.05.007
|